Status: 02.08.2022 2:17 p.m.
In Germany, for the first time, young people have also been infected with monkeypox. So far, a total of 2,724 cases have been reported to the RKI – by far most of them in Berlin.
About three months after the first detection of monkeypox in Germany, the Robert Koch Institute (RKI) speaks for the first time of known infections in minors. According to the RKI’s inventory, two cases concern young people. All other infected people are adults. First, the “Spiegel” reported two victims aged 15 and 17.
As an RKI database shows, case reports come from Stuttgart and Erfurt, relate to the first half of July (report weeks 27 and 28) and adolescent males. A total of 2724 infections from all federal states have now been transmitted to the RKI, almost exclusively from men.
Highest incidence in Berlin
“According to current knowledge, transmissions in this outbreak are primarily occurring through sexual activity, currently particularly among men who have sexual contact with other men,” the RKI said. “So far, only five female cases have been reported in Germany.” The incidence is by far highest in Berlin – more than 1,300 cases have been reported in the capital. “As far as is known, most of those affected do not become seriously ill,” according to the RKI.
The death rate in countries outside Africa remains “extremely low”, said Jürgen Rockstroh, head of the outpatient clinic for infectious diseases and immunology at Bonn University Hospital. In recent days, several monkeypox deaths have been reported in countries where the disease is new, including two in Spain. However, the expert sees several reasons for this: For example, the declaration of a health emergency of international scope by the World Health Organization (WHO) a few days ago may have made it possible to improve surveillance.
At the same time, there are now over 20,000 cases worldwide, so more cases are being assessed. Rockstroh also said people’s illnesses should be recorded in order to find factors that increase the risk of hospitalization and death. Severe immunosuppression appears to increase the risk of adverse outcome.